Skip to content
WeighLab

MyDrHank vs Basal Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MyDrHank

Affiliate partner

Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.

Semaglutide / month
$249/moOral, $259/mo injectable (yearly prepay: $171 / $178)
Tirzepatide / month
$349/moMonth-to-month ($240/mo only on a year prepaid)
Index 65/100 · Grade CChecked October 2026

Basal Health

Provider comparison

Patients seeking tirzepatide who want the regular renewal price disclosed before intake and can budget for thirteen yearly cycles.

Semaglutide / month
Not disclosed
Tirzepatide / month
$299Every 4 weeks (all doses, compounded; $149 introductory first cycle)
Index 67/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Basal Health has the higher Cost-Efficiency Index: 67/100 versus 65/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

MyDrHank
Not published; program excludes KS, LA, MS, NM, ND, WV
Basal Health
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MyDrHank

Basal Health

Semaglutide / month
MyDrHank: $249/moOral, $259/mo injectable (yearly prepay: $171 / $178)
Basal Health: Not disclosed
Tirzepatide / month
MyDrHank: $349/moMonth-to-month ($240/mo only on a year prepaid)
Basal Health: $299Every 4 weeks (all doses, compounded; $149 introductory first cycle)
Semaglutide / year (modeled)
MyDrHank: $2,988
Basal Health: —
Tirzepatide / year (modeled)
MyDrHank: $4,188
Basal Health: $3,88713 charges
State availability
MyDrHank: Not published; program excludes KS, LA, MS, NM, ND, WV
Basal Health: All 50 states
Oral / sublingual option listed
MyDrHank: Yes
Basal Health: Not listed
Brand-name access listed
MyDrHank: Not confirmed
Basal Health: Not confirmed
Provider facts checked
MyDrHank: October 2026
Basal Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MyDrHank

Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.

Reasons to consider it

  • The price does not change as your dose is titrated up — its FAQ states it plainly ("The price stays the same at every dose — no surprise price increases"), and dose-indexed pricing is the single most common way a cheap first month becomes an expensive fourth one
  • A genuine oral route on semaglutide: a daily tablet, including one compounded with low-dose ondansetron specifically to blunt the nausea that ends most GLP-1 courses early
  • Every plan length is priced in public — monthly, quarterly, 6-month and yearly, with the total for each term printed beside the per-month figure — before any quiz, intake or email capture

What to weigh up

  • EVERY price the site advertises is a twelve-month prepay rate, and not by accident: the price display always shows the cheapest plan, so "From $X/mo" is always the yearly figure. No page shows a month-to-month rate beside it
  • What the twelve months actually cost, up front: oral semaglutide $2,057 to reach the advertised $171/mo, injectable semaglutide $2,140 to reach $178/mo, and tirzepatide $2,883 to reach $240/mo
  • "Plans start at $171/mo with no contract" is the site's own FAQ wording, and its own price list contradicts it — $171 exists only on the Yearly plan. The genuinely no-contract price is $249

Basal Health

Patients seeking tirzepatide who want the regular renewal price disclosed before intake and can budget for thirteen yearly cycles.

Reasons to consider it

  • Publishes $149 for the first four weeks and $299 every four weeks thereafter
  • Same price at every dose, with no membership fee
  • Serves all 50 states and Washington, D.C.

What to weigh up

  • Four-week billing means thirteen regular-rate charges in a modeled year
  • Semaglutide is not listed as a treatment option
  • The dispensing pharmacy and individual medical director are not named

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MyDrHankBasal Health
Normalized Cost/Month
MyDrHank:
56/100
Basal Health:
48/100
Price Transparency
MyDrHank:
52/100
Basal Health:
94/100
Nationwide Access
MyDrHank:
62/100
Basal Health:
86/100
Formulation Options
MyDrHank:
88/100
Basal Health:
53/100
Clinical Oversight
MyDrHank:
66/100
Basal Health:
61/100
Contract Flexibility
MyDrHank:
80/100
Basal Health:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.